Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Taking endocrine therapy before surgery may reduce the number of repeat operations. This would also benefit women with smaller tumours.

It may also mean that less tissue needs to be removed allowing for a better cosmetic result, or that more complex oncoplastic (breast tissue rearrangement) surgery is not needed.

Mammograms and scans help us estimate the tumour size before surgery. We won’t know the exact size of the tumour until it is removed at your operation and analysed under a microscope.

We know that further operations are needed in around 1 in 5 (or 20% of) women who have a lumpectomy. This is because cancer was very close to the edge (or “margin”) of tissue removed at the first operation.

This often happens when the tumour ends up being larger under the microscope than expected from mammograms or ultrasound.